News About: Pharm. Affairs
Impossibility to export biosimilar drug price at 30% of foreign prices
In order for biopharmaceutical products, which have been chosen as a new growth industrial power by the government, to have expansion and leadership in the global market, the biopharmaceutical industry has raised a st...
Listed pharmaceutical companies’ market capitalization evaporated by KRW 11.64 trillion in 3 months
As the bubble in pharmaceutical and biopharmaceutical stocks has been controversy in the second half of the year, it was observed market capitalizations of domestic listed pharmaceutical companies(including biopharmac...
2014 pharmaceutical market increased in export, but remained in average annual growth rate
Exports were slightly increased in the pharmaceutical market in 2014, but its growth rate was about the same compared to the year before.
According to the ‘2015 Annual Report of Food and Drug Statistics’ of the Minis...
Inconvenient osteoporosis drugs to be changed to liquid and effervescent tabs
Osteoporosis, a disease weakening bone strength, is frequently found in post-menopausal middle-aged women. Those patients usually use bisphosphonate-type drugs, which are awfully inconvenient.
Bisphosphonate-type dru...
Patent expiration of ‘Baraclude’ different from Cialis
A large blockbuster market worth of KRW 150 billion sales will be opened. However, it was analyzed its generic market will be limited. It basically proves the importance of new drug development and the present conditi...
Feburic generics acquired additional sales approvals
Generic development of Feburic Tab(febuxostat), a gout treatment, has been fueled.
The Ministry of Food and Drug Safety(MFDS) decided prohibition of its generic sales by the request of the patentee(the original compa...
Cialis generic war led by Cendom and Gugu on the early phase
On the early phase of the Cialis generic market, Chong Kun Dang’s ‘Cendom’ took the lead. Hanmi Pharm’s ‘Gugu’ outdistanced Cialis, the original, in prescription.
In the market where 60 pharmaceutical companies jumpe...
Why there are only imported oral contraceptives having no patent?
There are the total 11 oral contraceptives distributed in Korea.
Among them Crown Pharm’s ‘Sexcon Tab’ is the only product manufactured in the domestic industry; however, its market share is less than 2%.
Every famo...
Approval of ‘Cosentyx,’ a new psoriasis treatment
‘Cosentyx(generic name: secukinumab),’ a Novartis’s new psoriasis treatment, has acquired approval. It is a next-generation new drug which will compete with Janssen’s Stelara.
The Ministry of Food and Drug Safety app...
Useful GLP-1 analogues reduced by 5.5% in price
From the next month, the health insurance ceiling prices of GLP-1 analogues have been reduced by 5.5%, which were expected to be improved in the health insurance benefit standard.
According to the partial amendment f...
